强力定眩胶囊联合甲磺酸倍他司汀片治疗眩晕症临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R441.2;R248

基金项目:


Clinical Study on Qiangli Dingxuan Capsules Combined with Betahistine Mesilate Tablets for Vertigo
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察强力定眩胶囊联合甲磺酸倍他司汀片治疗眩晕症的临床效果。方法:将 88 例眩晕症患者按随机数字表法分为观察组和对照组各 44 例。2 组均给予护理干预,对照组给予甲磺酸倍他司汀片治疗,观察组在对照组基础上给予强力定眩胶囊治疗。比较 2 组临床疗效,检测治疗前后血流动力学指标及血清中人降钙素基因相关肽 (CGRP)、内皮素-1 (ET-1) 水 平,观察不良反应发生情况。结果:观察组总有效率为 95.45%,高于对照组 77.27%,差异有统计学意义 (P<0.05)。治疗后, 2 组基底动脉 (BA)、右椎动脉 (RVA) 以及左椎动脉 (LVA) 血流速度较治疗前升高 (P<0.05),且观察组 BA、RVA 及 LVA血流速度均高于对照组 (P<0.05)。治疗后,2 组 CGRP 水平较治疗前升高,ET-1 水平较治疗前降低 (P<0.05);且观察组CGRP 水平高于对照组,ET-1 水平低于对照组(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:强力定眩胶囊联合甲磺酸倍他司汀片治疗眩晕症可有效缓解患者头晕等临床症状,改善血流动力学指标,疗效显著。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Qiangli Dingxuan capsules combined with betahistine mesilate tablets for vertigo. Methods:A total of 88 cases patients with vertigo were divided into the observation group and the control group according to the random number table method,44 cases in each group. Both groups were given nursing intervention; the control group was given betahistine mesilate tablets,and the observation group was additionally given Qiangli Dingxuan capsules based on the treatment of the control group. The clinical effect was compared between the two groups. Hemodynamics indexes as well as levels of human calcitonin gene-related peptide(CGRP) and endothelin-1(ET-1) in serum before and after treatment were detected. The incidence of adverse reactions was observed. Results:The total effective rate was 95.45% in the observation group, higher than that of 77.27% in the control group, the difference being significant (P<0.05). Before treatment,when compared blood flow velocity of basilar artery(BA),right vertebral artery(RVA),and left vertebral artery(LVA) between the two groups,there was no significance in the difference(P>0.05). After treatment,blood flow velocity of basilar artery(BA),right vertebral artery(RVA),and left vertebral artery(LVA) in the two groups was increased when compared with that before treatment(P<0.05),and blood flow velocity of the arteries above in the observation group was higher than that in the control group(P<0.05). After treatment,levels of CGRP in the two groups were increased when compared with those before treatment,and levels of ET-1 were decreased(P<0.05);level of CGRP in the observation group was higher than that in the control group,and level of ET-1 was lower(P<0.05). There was no significant difference being found in the comparison of the incidence of adverse reactions between the two groups(P>0.05). Conclusion: In the treatment of vertigo,the therapy of Qiangli Dingxuan capsules combined with betahistine mesilate tablets can effectively relieve clinical symptoms like dizziness,and improve hemodynamics indexes,with significant curative effect.

    参考文献
    相似文献
    引证文献
引用本文

吴海萍.强力定眩胶囊联合甲磺酸倍他司汀片治疗眩晕症临床研究[J].新中医,2021,53(7):135-138

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-04-08
  • 出版日期:
文章二维码